Amarin Corp plc (ADR) (NASDAQ:AMRN)
CAPS Rating:
The Company is engaged in the research, development and commercialization of novel drugs for the treatment of central nervous system disorders.
The Company is engaged in the research, development and commercialization of novel drugs for the treatment of central nervous system disorders.
Recs
Too much supply in market already. There is nothing unique about purified fish oil except marketing.
It sounds like you have a negative opinion of the product. Why the up thumb?